ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Inflammation"

  • 2016 American Transplant Congress

    C1-Inhibitor Abrogated Ischemia/Reperfusion (I/R) Induced Inflammaging by Inhibiting Senescence-Associated Secretory Phenotype (SASP) in Tubular Epithelial Cells (TEC).

    G. Castellano,1 R. Franzin,1 A. Stasi,1 C. Divella,1 M. Gigante,1 S. Simone,1 A. Intini,1 A. Picerno,1 P. Pontrelli,1 A. Crovace,1 M. Battaglia,1 B. Oortwijn,2 E. Amersfoort,2 G. Grandaliano,3 L. Gesualdo.1

    1Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy; 2Pharming Technologies, Leiden, Netherlands; 3Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.

    Inflammaging is a pathogenic process usually associated with chronic kidney disease such as diabetic nephropathy where TEC cells have a diminished regenerative potential and develop…
  • 2016 American Transplant Congress

    Hif-1α Stabilization in the Recipient Accelerates Cardiac Allograft Rejection.

    Z. Ilyas, M. DeBerge, S. Dehn, J.-J. Wang, Z. Zhang, E. Thorp, M. Ansari.

    Northwestern University, Chicago.

    Introduction: Increased Hif-1α mRNA expression in deceased-donor organ transplant tissue prior to or soon after transplantation significantly correlated with primary graft dysfunction. HIF-1α is positioned…
  • 2016 American Transplant Congress

    Long Term Heterotopic Cardiac Xenograft Survival from Donor Pigs with Six Gene Modifications.

    M. Mohiuddin,1 A. Singh,1 J. Chan,1 P. Corcoran,1 M. Thomas III,2 B. Lewis,2 D. Ayares,3 K. Horvath.1

    1CSRP, NHLBI/NIH, Bethesda, MD; 2DVR / RS, NIH, Bethesda, MD; 3Revivicor, Inc, Blacksburgh, VA.

    Introduction: We have recently reported pig xenograft survival of more than 2.5 years in a heterotopic cardiac xenograft model. Some of the animals exhibited local…
  • 2016 American Transplant Congress

    Tumor-Necrosis-Factor-α Antagonist Therapy for Inflammatory Bowel Disease After Liver Transplantation.

    R. Parekh, M. Segovia, N. Kaur.

    Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI.

    Background:The safety and effectiveness of tumor-necrosis-factor-α antagonist (anti-TNF-α) therapy for inflammatory bowel disease (IBD) has not been well-established in patients after liver transplantation (LT). We…
  • 2016 American Transplant Congress

    Rapamycin Encapsulated Nanoparticles as Pre-Treatment in Lung Transplantation.

    G. Bazzle,1 S. Dixit,2 K. Patel,3 A.-M. Broome,2 S. Nadig,1,3 C. Atkinson.1,3

    1Microbiology and Immunology, Medical University of South Carolina, Charleston, SC; 2Department of Radiology, Medical University of South Carolina, Charleston, SC; 3Department of Surgery, Medical University of South Carolina, Charleston, SC.

    Introduction: While short-term lung transplant outcomes have improved over the years, long-term survival rates remain stagnant. Many injuries occur to the donor organ before transplantation,…
  • 2016 American Transplant Congress

    Multiplex Profiling of Plasma Proteins After Xenogenic Lung Exposure.

    A. Azimzadeh,1 N. Cheng,1 X. Cheng,1 E. Schwartz,1 L. Burdorf,1 S. Dahi,1 N. Kubicki,1 D. Parsell,1 T. Zhang,1 D. Cooper,2 C. Phelps,3 D. Ayares,3 R. Pierson III.1

    1Univ. Of Maryland, Baltimore, MD; 2University of Pittsburgh, Pittsburgh, PN; 3Revivicor, Blacksburg, VA.

    Background: Porcine lungs exhibit injury by human blood and are only partially protected in GalTKO organs with additional human membrane cofactor protein (hCD46). Residual injury…
  • 2016 American Transplant Congress

    Inflammatory Conditions Switch the Effect of MSC on B Cells from Pro-Tolerogenic to Anti-Proliferative.

    M. Franquesa,1,2 F. Luk,1 S. Korevaar,1 L. Boon,3 F. Borras,2 M. Betjes,1 C. Baan,1 M. Hoogduijn.1

    1Transplantation and Nephrology Lab, Internal Medicine, Erasmus MC, Rotterdam, Netherlands; 2IVECAT, Nephrology Department, IGTP, Badalona, Spain; 3Bioceros, Utrecht, Netherlands.

    The immunomodulatory capacity of mesenchymal stem cells (MSC) makes them a promising therapeutic tool in transplantation. MSC are recently gaining interest for their immunomodulatory effects…
  • 2016 American Transplant Congress

    Microfluidics to Characterize Leukocyte Trafficking into Allografts and the Resolution of Inflammation.

    L. Boneschansker,1,2 D. Irimia,2 D. Briscoe.1

    1Transplant Research Program, Boston Children's Hospital, Boston; 2MGH, Boston.

    Pro-resolution mediators such as resolvins and axonal guidance receptor-ligand interactions are increasingly recognized to regulate leukocyte trafficking into sites of inflammation. The implication of this…
  • 2016 American Transplant Congress

    The Immunologic Profile of Brain Death in Humans: A Whole-Body Analysis.

    D. Carpenter,1,2 N. Matsuoka,1 J. Thome,1,3 T. Granot,1,3 C. Gordon,1,3 B. Kumar,1,3 T. Senda,1,3 M. Miron,1,3 J. Weiner,2 A. Griesemer,1,2 D. Farber.1,2,3

    1Columbia Center for Translational Immunology, Columbia University Medical Center, New York City, NY; 2Surgery, Columbia University Medical Center, New York City, NY; 3Microbiology and Immunology, Columbia University Medical Center, New York City, NY.

    Transplantation outcomes are believed to be influenced by a generalized inflammatory state caused by brain death itself or events in the peri-transplant period. Studies on…
  • 2016 American Transplant Congress

    Optimizing the Immunogenicity and Immunomodulatory Properties of MSC for Cellular Therapy.

    S. de Witte,1 M. Franquesa,1 T. Strini,1 S. Korevaar,1 F. Luk,1 S. Elliman,2 P. Newsome,3 M. Gargesha,4 D. Roy,4 A. Merino,1 C. Baan,1 M. Hoogduijn.1

    1ErasmusMC, Rotterdam, Netherlands; 2Orbsen Therapeutics, Galway, Ireland; 3University of Birmingham, Birmingham, United Kingdom; 4Bioinvision, Mayfield Village.

    Mesenchymal stromal cells (MSC) are candidates for immunotherapy after transplantation. MSC have shown to be immunomodulatory and low immunogenic, which is favorable for cellular therapy…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 41
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences